AU2001276549A1 - Transglutaminase for inhibiting angiogenesis - Google Patents

Transglutaminase for inhibiting angiogenesis

Info

Publication number
AU2001276549A1
AU2001276549A1 AU2001276549A AU7654901A AU2001276549A1 AU 2001276549 A1 AU2001276549 A1 AU 2001276549A1 AU 2001276549 A AU2001276549 A AU 2001276549A AU 7654901 A AU7654901 A AU 7654901A AU 2001276549 A1 AU2001276549 A1 AU 2001276549A1
Authority
AU
Australia
Prior art keywords
transglutaminase
inhibiting angiogenesis
angiogenesis
inhibiting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001276549A
Inventor
Martin Griffin
Richard Jones
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nottingham Trent University
Original Assignee
Nottingham Trent University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nottingham Trent University filed Critical Nottingham Trent University
Publication of AU2001276549A1 publication Critical patent/AU2001276549A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU2001276549A 2000-08-08 2001-08-08 Transglutaminase for inhibiting angiogenesis Abandoned AU2001276549A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0019302.9 2000-08-08
GBGB0019302.9A GB0019302D0 (en) 2000-08-08 2000-08-08 Biological materials and the use thereof for the treatment of disease
PCT/GB2001/003574 WO2002011747A2 (en) 2000-08-08 2001-08-08 Transglutaminase for inhibiting angiogenesis

Publications (1)

Publication Number Publication Date
AU2001276549A1 true AU2001276549A1 (en) 2002-02-18

Family

ID=9897087

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001276549A Abandoned AU2001276549A1 (en) 2000-08-08 2001-08-08 Transglutaminase for inhibiting angiogenesis

Country Status (5)

Country Link
US (1) US7704943B2 (en)
EP (1) EP1311287A2 (en)
AU (1) AU2001276549A1 (en)
GB (1) GB0019302D0 (en)
WO (1) WO2002011747A2 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060205080A1 (en) * 2005-03-01 2006-09-14 David Frey Formulations for therapeutic viruses having enhanced storage stability
RU2011142172A (en) * 2009-03-19 2013-04-27 Квинсленд Юниверсити Оф Текнолоджи TARGETS FOR SIGNALS OF GROWTH FACTOR AND METHODS OF TREATMENT
EP2547328B1 (en) * 2010-02-11 2017-06-07 Ecole Polytechnique Fédérale de Lausanne (EPFL) Ccr7 ligand delivery and co-delivery in immunotherapy
US9850296B2 (en) 2010-08-10 2017-12-26 Ecole Polytechnique Federale De Lausanne (Epfl) Erythrocyte-binding therapeutics
US9518087B2 (en) 2010-08-10 2016-12-13 Ecole Polytechnique Federale De Lausanne (Epfl) Erythrocyte-binding therapeutics
US9517257B2 (en) 2010-08-10 2016-12-13 Ecole Polytechnique Federale De Lausanne (Epfl) Erythrocyte-binding therapeutics
GB2490547A (en) * 2011-05-06 2012-11-07 Univ Aston Tissue transglutaminase inhibitors for use in the treatment of angiogenesis
MX2014009900A (en) 2012-02-15 2015-06-02 Ecole Polytech Erythrocyte-binding therapeutics.
EP3046577A4 (en) * 2013-09-20 2017-04-05 Landegren, Nils A novel autoantigen
JP6744227B2 (en) 2014-02-21 2020-08-19 エコール・ポリテクニーク・フェデラル・ドゥ・ローザンヌ（ウペエフエル）Ｅｃｏｌｅ Ｐｏｌｙｔｅｃｈｎｉｑｕｅ Ｆｅｄｅｒａｌｅ ｄｅ Ｌａｕｓａｎｎｅ （ＥＰＦＬ） Sugar-targeted therapeutic agent
US10046056B2 (en) 2014-02-21 2018-08-14 École Polytechnique Fédérale De Lausanne (Epfl) Glycotargeting therapeutics
US10953101B2 (en) 2014-02-21 2021-03-23 École Polytechnique Fédérale De Lausanne (Epfl) Glycotargeting therapeutics
US10946079B2 (en) 2014-02-21 2021-03-16 Ecole Polytechnique Federale De Lausanne Glycotargeting therapeutics
EP3638296A1 (en) 2017-06-16 2020-04-22 The University Of Chicago Compositions and methods for inducing immune tolerance
CA3094345A1 (en) * 2018-04-12 2019-10-17 Krystal Biotech, Inc. Compositions and methods for the treatment of autosomal recessive congenital ichthyosis

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9223084D0 (en) 1992-11-04 1992-12-16 Imp Cancer Res Tech Compounds to target cells
US6852318B1 (en) * 1998-05-08 2005-02-08 The Regents Of The University Of California Methods for detecting and inhibiting angiogenesis

Also Published As

Publication number Publication date
GB0019302D0 (en) 2000-09-27
EP1311287A2 (en) 2003-05-21
US20040028674A1 (en) 2004-02-12
US7704943B2 (en) 2010-04-27
WO2002011747A3 (en) 2002-08-08
WO2002011747A2 (en) 2002-02-14

Similar Documents

Publication Publication Date Title
AU2001274288A1 (en) Centraliser
AU2002225730A1 (en) Compounds
AU2001274302A1 (en) Centraliser
AU2001254546A1 (en) Aminopiperidines
AU2001239310A1 (en) Decahydro-isoquinolines
AU2001265089A1 (en) Rc-timer scheme
AU2001237637A1 (en) Centraliser
AU3942901A (en) Navigational aid
AU2001276549A1 (en) Transglutaminase for inhibiting angiogenesis
AUPQ661800A0 (en) Insulin-potentiating compounds
AU2001265871A1 (en) Substituted sulfonylaminopyrimidines
AU2001258255A1 (en) Substituted benzoylcyclohexenones
AU2002356180A1 (en) Methods for inhibiting angiogenesis
AU2001254731A1 (en) Substituted phenyluracils
AU2001220281A1 (en) Rollerboard for road-skiing
AU2002225724A1 (en) Motilide compounds
AU2001294866A1 (en) Transferases
AU2002217285A1 (en) Compounds
AU2001277581A1 (en) Myocardium-specific promoter
AU2001246864A1 (en) Hypotensors
AU2001262729A1 (en) 4-oxoimidazolidine-2-spiro-nitrogenous heterocycle compounds
AU2002223604A1 (en) Substituted phenyluracils
AU5822601A (en) Headstock
AU2001226668A1 (en) Crankshaft-starter-generator
AU4859301A (en) Antihistaminic compounds